Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
Abstract Deficits in protein synthesis are associated with Parkinson’s disease (PD). However, it is not known which proteins are affected or if there are synthesis differences between patients with sporadic and Leucine-Rich Repeat Kinase 2 (LRRK2) G2019S PD, the most common monogenic form. Here we u...
Main Authors: | Dani Flinkman, Ye Hong, Jelena Gnjatovic, Prasannakumar Deshpande, Zsuzsanna Ortutay, Sirkku Peltonen, Valtteri Kaasinen, Peter James, Eleanor Coffey |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-023-00460-w |
Similar Items
-
LRRK2 and Proteostasis in Parkinson’s Disease
by: María Dolores Pérez-Carrión, et al.
Published: (2022-06-01) -
Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3.
by: Njideka Okubadejo, et al.
Published: (2008-01-01) -
Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson’s disease
by: Hsin Fen Chien, et al.
Published: (2014-05-01) -
Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
by: Hongwon Kim, et al.
Published: (2019-03-01) -
Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson’s Disease: A Pilot Study
by: Ali Yilmaz, et al.
Published: (2020-10-01)